Kiniksa Pharmaceuticals International, plc (KNSA)
CIK 1730430 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Kiniksa Pharmaceuticals International, plc.
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Sep 3, 2026 | 4 | 0001464583-26-000008 |
| Sep 3, 2026 | 4 | 0001857177-26-000008 |
| Sep 3, 2026 | 4 | 0001532218-26-000014 |
| Sep 3, 2026 | 4 | 0001835458-26-000012 |
| Sep 3, 2026 | 144 | 0001921094-26-000988 |
| Sep 3, 2026 | 4 | 0001532218-26-000016 |
| Sep 3, 2026 | 4 | 0001741533-26-000010 |
| Aug 21, 2026 | 4 | 0001384243-26-000014 |
| Aug 4, 2026 | 4 | 0001454983-26-000008 |
| Jul 31, 2026 | 4 | 0001337798-26-000004 |
| Jul 29, 2026 | 144 | 0001921094-26-000768 |
| Jul 29, 2026 | SCHEDULE 13G | 0002012383-26-002783 |
| Jul 29, 2026 | 144 | 0001921094-26-000767 |
| Jul 28, 2026 | 10-Q | 0001104659-26-087545 |
| Jul 28, 2026 | 8-K | 0001730430-26-000031 |
| Jul 6, 2026 | 3 | 0002143491-26-000002 |
| Jul 6, 2026 | 4 | 0002143491-26-000004 |
| Jun 2, 2026 | 4 | 0001403322-26-000002 |
| Jun 2, 2026 | 4 | 0001683600-26-000002 |
| Jun 2, 2026 | 4 | 0001193125-26-253615 |
| Jun 2, 2026 | 4 | 0001454983-26-000004 |
| Jun 2, 2026 | 4 | 0001384243-26-000012 |
| Jun 2, 2026 | 4 | 0001337798-26-000002 |
| Jun 2, 2026 | 4 | 0001532218-26-000012 |
| Jun 2, 2026 | 4 | 0001333482-26-000002 |